Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Curr Opin Virol. 2020 Apr 1;41:8–17. doi: 10.1016/j.coviro.2020.02.007

Figure 1.

Figure 1.

Timeline of MeV load, clinical signs (fever and rash), and immunosuppression phase during acute measles based on [59]. Approximate efficacy cut-offs for post-exposure vaccination and measles IgG PEP are shown.